top of page
Black Metal_edited.jpg

OPTIC

Ocular Photoreceptor Integration for Therapeutic Intervention and Compensation

OPTIC_Biomimetic_front_page.png
image.png

Ocular Prosthetics

Ocular Prosthetics are our vision for the future of vision restoration as they will provide a reliable solution to cure retinal degenerative diseases and assist those suffering from vision loss regain their sight.

How does OPTIC work?

image.png

OPTIC utilizes synthetic photoreceptors made of Quantum Dots (QDs) to replace damaged rods and cones in the patient's retina. The scaffold is composed of Cell Adhesion Molecules (CAMs) which align and attach the synthetic photoreceptors to remaining retinal cells, if any. Hyaluronic Acid (HA) Hydrogel will then act by supporting tissue regeneration. A flexible, high-density electrode array will then transmit the interpreted electrical signals for the photoreceptors to the brain through the optic nerve. This, overall, presents a reliable prosthetic solution to mimic the natural vision processing which was initially interrupted by the degenerative diseases.

Why is it important?

<10%

Treatment Success rate of Traditional Laser Therapy for RP

12%

Of people will will develop age-related macular degeneration (AMD) in their lifetime.

400M+

People Affected Worldwide

1 in 4,000

Has Retinitis Pigmentosa (RP)

$49B

Annual Economic Burden caused by Age-Related Macular Degeneration (AMD)

Our Mission

OPTIC is not just science. It's a promise of light for those lost in darkness. Vision isn't merely about seeing—it's about truly living. With our project, we aim to restore vision to over 250 million people globally with cost-effective, scalable manufacturing. With OPTIC, we aim to breakthrough and improve vision acuity in a way that has never been implemented before. With OPTIC, the future of vision begins today.

bottom of page